FDA releases denial letters for unapproved drugs, a step toward transparency BPC 157: Experimental Peptide Creates Risk for Athletes FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019 FDA Warning Letters Sent to Pet Product Companies NASC LIVE In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law